As part of the due diligence process, pharmaBank screens and analyses potential projects and addresses the following main criteria:

• In Phase I, Phase I ready, or at an advanced preclinical stage;
• Large potential market size with an emphasis on international markets;
• Clear ownership and protection of Intellectual property, in particular patent protection;
• High market growth potential;
• Technology to be differentiated from that of its competitors; and
• There must be a potential and appropriate financial rate of return.

These criteria are not an exhaustive list.  pharmaBank reserves the right to apply other appropriate criteria as it deems appropriate.